Patent Assignment
Reel/Frame 059369/0256
Change of Name
Recorded: 2022-03-16
Pages: 4
Assignor
LUC THERAPEUTICS, INC.
Executed: 2017-04-06
Assignee
CADENT THERAPEUTICS, INC.
400 TECHNOLOGY SQ., 10TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Selective Octahydro-Cyclopenta[C]Pyrrole Negative Modulators of NR2B
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Mar 16, 2022
From: MNEMOSYNE PHARMACEUTICALS, INC.
To: LUC THERAPEUTICS, INC.
Reel/Frame 059369/0242 →
Assignment of Assignor's Interest
Mar 16, 2022
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.
To: MNEMOSYNE PHARMACEUTICALS, INC.
Reel/Frame 059369/0246 →
Assignment of Assignor's Interest
Jan 25, 2023
From: CADENT THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 062486/0654 →